目的对人A组轮状病毒进行检测及分离鉴定,并研究其各基因片段的遗传进化关系。方法2019-2020年对湖北武汉市和襄阳市临床腹泻病人的粪便样品进行采集,共319份。设计特异性轮状病毒VP6基因引物,RT-PCR检测轮状病毒的感染情况。将阳性样...目的对人A组轮状病毒进行检测及分离鉴定,并研究其各基因片段的遗传进化关系。方法2019-2020年对湖北武汉市和襄阳市临床腹泻病人的粪便样品进行采集,共319份。设计特异性轮状病毒VP6基因引物,RT-PCR检测轮状病毒的感染情况。将阳性样品接种于MA104细胞进行轮状病毒的分离。RT-PCR特异性扩增VP6基因和特异性间接免疫荧光对其进行病毒鉴定及病毒增殖检测;并进一步通过RT-PCR扩增轮状病毒的11个基因片段,在线工具Rota C V2.0对测序结果进行分型分析。Mega软件对其全基因组序列进行遗传进化分析。结果轮状病毒感染阳性标本共69份,阳性率为21.63%。成功分离获得11株人轮状病毒,主要衣壳蛋白VP7和VP4基因型均为G9P[8]型。其中3株轮状病毒归属于类Wa株毒株,基因型图谱为G9-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1。8株毒株在Wa-like的基因型中具有DS-1-like的NSP4为E2基因型特征。基因型图谱为G9-P[8]-I1-R1-C1-M1-A1-N1-T1-E2-H1。结论G9P[8]型人轮状病毒毒株在2019-2020年湖北部分地区占主导趋势,且其NSP4基因以E2基因型为主要流行形式。展开更多
To construct the bi-valent genetic engineering vaccine against pseudorabies virus（PRV）and porcine reproductive and respiratory syndrome virus（PRRSV）,the modified PRRSV ORF5 gene（ORF5M） and the VP22 gene of bovin...To construct the bi-valent genetic engineering vaccine against pseudorabies virus（PRV）and porcine reproductive and respiratory syndrome virus（PRRSV）,the modified PRRSV ORF5 gene（ORF5M） and the VP22 gene of bovine herpesvirus 1（BHV-1）,which encodes VP22 protein and has been demonstrated to exhibit the unusual protein transduction property,were inserted into a PRV universal transfer vector pIECMV by turns.A recombinant virus transfer vector pIECMV-VP22ORF5M possessing VP22-ORF5M fusion gene was generated.The recombinant virus transfer vector pIECMV-VP22ORF5M co-transfected the IBRS-2 cells with PRV TK-/gE-/LacZ+ genomic DNA digested by EcoRⅠusing liposome method.Based on homologous recombination,the recombinant virus was generated and then purified by the plaque assay and PCR amplification.After three rounds of plaque purification,the recombinant virus was further confirmed by PCR,Southern blot and Western blot.A recombinant PRV（rPRV）TK-/gE-/VP22GP5+ expressing VP22-GP5 fusion protein was constructed.The results of TCID50 tests showed that the insertion of the foreign genes had no influence on the propagation of rPRV in IBRS-2 or PK-15 cells.The construction of rPRV TK-/gE-/VP22GP5+ provides a basis for further study of bi-valent genetic engineering vaccines against PRRSV and PRV,and that this strategy may also be useful to develop more efficient genetic engineering vaccines against other pathogens.展开更多
文摘目的对人A组轮状病毒进行检测及分离鉴定,并研究其各基因片段的遗传进化关系。方法2019-2020年对湖北武汉市和襄阳市临床腹泻病人的粪便样品进行采集,共319份。设计特异性轮状病毒VP6基因引物,RT-PCR检测轮状病毒的感染情况。将阳性样品接种于MA104细胞进行轮状病毒的分离。RT-PCR特异性扩增VP6基因和特异性间接免疫荧光对其进行病毒鉴定及病毒增殖检测;并进一步通过RT-PCR扩增轮状病毒的11个基因片段,在线工具Rota C V2.0对测序结果进行分型分析。Mega软件对其全基因组序列进行遗传进化分析。结果轮状病毒感染阳性标本共69份,阳性率为21.63%。成功分离获得11株人轮状病毒,主要衣壳蛋白VP7和VP4基因型均为G9P[8]型。其中3株轮状病毒归属于类Wa株毒株,基因型图谱为G9-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1。8株毒株在Wa-like的基因型中具有DS-1-like的NSP4为E2基因型特征。基因型图谱为G9-P[8]-I1-R1-C1-M1-A1-N1-T1-E2-H1。结论G9P[8]型人轮状病毒毒株在2019-2020年湖北部分地区占主导趋势,且其NSP4基因以E2基因型为主要流行形式。
文摘To construct the bi-valent genetic engineering vaccine against pseudorabies virus（PRV）and porcine reproductive and respiratory syndrome virus（PRRSV）,the modified PRRSV ORF5 gene（ORF5M） and the VP22 gene of bovine herpesvirus 1（BHV-1）,which encodes VP22 protein and has been demonstrated to exhibit the unusual protein transduction property,were inserted into a PRV universal transfer vector pIECMV by turns.A recombinant virus transfer vector pIECMV-VP22ORF5M possessing VP22-ORF5M fusion gene was generated.The recombinant virus transfer vector pIECMV-VP22ORF5M co-transfected the IBRS-2 cells with PRV TK-/gE-/LacZ+ genomic DNA digested by EcoRⅠusing liposome method.Based on homologous recombination,the recombinant virus was generated and then purified by the plaque assay and PCR amplification.After three rounds of plaque purification,the recombinant virus was further confirmed by PCR,Southern blot and Western blot.A recombinant PRV（rPRV）TK-/gE-/VP22GP5+ expressing VP22-GP5 fusion protein was constructed.The results of TCID50 tests showed that the insertion of the foreign genes had no influence on the propagation of rPRV in IBRS-2 or PK-15 cells.The construction of rPRV TK-/gE-/VP22GP5+ provides a basis for further study of bi-valent genetic engineering vaccines against PRRSV and PRV,and that this strategy may also be useful to develop more efficient genetic engineering vaccines against other pathogens.
